--- title: A Sanofi case study in lung cancer | Inato description: How to dramatically accelerate clinical trials and sustain lower costs in complex and competitive environments image: https://blog.inato.com/hubfs/Blog%20Cover%20Updates%20(2200%20x%201260%20px)%20(2)-1.png --- [![Inato](https://blog.inato.com/hubfs/Inato.svg)](https://inato.com/home) - [For Sponsors](https://19510626.hs-sites.com/for-sponsors) - [Learn More](https://19510626.hs-sites.com/for-sponsors) - [Features](https://19510626.hs-sites.com/pre-screening-sponsors) - [AI Patient Pre-Screening](https://19510626.hs-sites.com/pre-screening-sponsors) - [AI Site Selection](https://19510626.hs-sites.com/site-selection) - [Early Planning](https://19510626.hs-sites.com/early-planning) - [Diversity](http://inato.com/diversity) - [FAQs](https://19510626.hs-sites.com/faqs-0) - [For Research Sites](https://19510626.hs-sites.com/for-sites) - [Learn More](https://19510626.hs-sites.com/for-sites) - Features - [AI Patient Pre-Screening](https://19510626.hs-sites.com/pre-screening-sites) - [FAQs](https://19510626.hs-sites.com/faqs) - [Company](https://19510626.hs-sites.com/about) - [About Us](https://19510626.hs-sites.com/about) - [Careers](https://19510626.hs-sites.com/careers) - [Innovation Board](https://19510626.hs-sites.com/innovation-board) - Resources - [Press Releases & News](https://19510626.hs-sites.com/news) - [Events](https://19510626.hs-sites.com/events) - [Marketplace Materials](https://19510626.hs-sites.com/marketplace-materials) - [Data Security & Privacy](https://19510626.hs-sites.com/security) - [Blog](https://blog.inato.com/blog) [SIGN IN](https://marketplace.inato.com/login) [DEMO](https://inato.com/contact) Product # A Sanofi case study in lung cancer How to dramatically accelerate clinical trials and sustain lower costs in complex and competitive environments [Admin](https://blog.inato.com/blog/author/admin) Nov 2, 2022 [mailto:?subject=Check%20out%20https://blog.inato.com/blog/sanofi-lung-cancer&utm_medium=social&utm_source=email%20&body=Check%20out%20https://blog.inato.com/blog/sanofi-lung-cancer&utm_medium=social&utm_source=email](mailto:?subject=Check%20out%20https://blog.inato.com/blog/sanofi-lung-cancer&utm_medium=social&utm_source=email%20&body=Check%20out%20https://blog.inato.com/blog/sanofi-lung-cancer&utm_medium=social&utm_source=email) --- ### Why This Webinar The rising costs of drug development have teams at every level of the process seeking new ways to streamline operations and cut expenses, especially in complex and competitive environments such as lung cancer. In this webinar we will share how Sanofi effectively planned for an upcoming lung cancer study while focusing on internal cost reduction goals. In this webinar we showcase how Sanofi was able to identify a far greater pool of sites with a high recruitment potential by utilizing latest machine learning technologies and combining internal and external databases. An innovative approach to study planning resulted in cost savings through the reduced number of countries and sites, and greater efficiency across the trial.   ### Webinar agenda Includes: - How to accelerate data collection across 47 countries - How to increase access to new sites and gain faster access to more patients - How to develop an evidence-based recruitment scenario - Next steps to improve country and site selection   Speakers ![caroline-lafitte](https://blog.inato.com/hs-fs/hubfs/Imported_Blog_Media/caroline_rounded_resized.png?width=298&height=298&name=caroline_rounded_resized.png "Caroline Lafitte") **Caroline Lafitte** Global Head, Feasibility and Competitive Intelligence Sanofi   Caroline Lafitte is leading a global team in charge of Competitive Intelligence and Feasibility within the Clinical Sciences Operational platform of Sanofi R&D. Caroline is in charge of Feasibility since more than 15 years and experienced in all therapeutic areas covered by Sanofi from Oncology to Rare Disorders, Blood disorders, Neurology and previously Diabetes and Cardiovascular. Her team is in charge of supporting protocol optimization of our study design as well as to define the most appropriate geographical distributions of our clinical studies using new technology, digital andreal worlddata. Caroline spent all of her career in R&D at various positions in Development within pharma industries. She started to work for Sanofi in 2002 and has a PHD in Physiology by training.   ![Liz-Beatty](https://blog.inato.com/hs-fs/hubfs/Liz-Beatty.png?width=299&height=299&name=Liz-Beatty.png) **Liz Beatty** Chief Strategy Officer Inato   Liz Beatty is the Chief Strategy Officer at Inato, whose platform increases the pool of available patients engaged in clinical trials by unlocking research site potential. Liz is focused on advancing Inato’s corporate strategy, developing partnerships and driving growth in North America. Previously, Liz was the Head of the Digital Clinical Trials team in Global Clinical Operations at Bristol-Myers Squibb. Her team leveraged innovative approaches to increase clinical trial awareness, transparency and participation, resulting in an enhanced clinical trial experience for patients and their care team. She was also the Chair of the Digital Acorn working group, which was a global, cross-functional team that brought digital innovation to clinical trials.  Liz previously held positions in clinical operations including managing a global patient recruitment team as well as various positions in protocol management and site management. [Product](https://blog.inato.com/blog/tag/product) ## Similar posts News ### [Multiple AbbVie Oncology Trials to Launch on the Inato Marketplace](https://blog.inato.com/blog/multiple-abbvie-oncology-trials-to-launch-on-the-inato-marketplace) A bundle of oncology trials from AbbVie is coming to the Inato marketplace. Emma Frane Jun 3, 2024 Industry Topics ### [Cutting Through the Chaos to Navigate Coronavirus Disease Clinical Trials](https://blog.inato.com/blog/cutting-through-the-chaos-to-navigate-corona-virus-disease-clinical-trials) Doctors grappling with fragmented data sources on COVID-19 trials can use Inato's Anticovid Platform to search trials, analyze trends, and act... Jennifer Kamara Mar 26, 2020 News ### [Sanofi and Inato join forces to bring Immunology research into communities across the world](https://blog.inato.com/blog/sanofi-and-inato-join-forces-to-bring-immunology-research-into-communities-across-the-world) In an effort to increase patient access to innovative investigational medicines, Sanofi will partner with Inato to connect with community-based sites... Admin Nov 2, 2022 [![Inato](https://blog.inato.com/hubfs/raw_assets/public/Inato_November2023/images/inato-logo.svg "Inato")](https://blog.inato.com/) - [For Sponsors](https://19510626.hs-sites.com/for-sponsors) - [For Research Sites](https://19510626.hs-sites.com/for-sites) - [Careers](https://19510626.hs-sites.com/careers) - [About Us](https://19510626.hs-sites.com/about) - [Inato Blog](https://blog.inato.com/blog) - [Contact](https://19510626.hs-sites.com/contact) ### Keep up with our latest trials, news & events Get Our Emails © 2023 Inato. All Rights Reserved. © 2025 Inato. All Rights Reserved. [Terms of Use](https://blog.inato.com/terms-of-use/) [Privacy Policy](https://blog.inato.com/privacy-policy/) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Admin", "url" : "https://blog.inato.com/blog/author/admin" }, "dateModified" : "2024-08-13T15:17:49.862Z", "datePublished" : "2022-11-02T19:59:09.000Z", "headline" : "A Sanofi case study in lung cancer | Inato", "image" : [ "https://blog.inato.com/hubfs/Blog%20Cover%20Updates%20(2200%20x%201260%20px)%20(2)-1.png" ], "mainEntityOfPage" : { "@id" : "https://blog.inato.com/blog/sanofi-lung-cancer", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.inato.com/hubfs/primary%20logo.png" }, "name" : "Inato" } } ```